Selzentry Side Effects
Links shared publicly online about this topic
facebook.com — “Facebook is a social utility that connects people with friends and others who work, study and live around them. People use Facebook to keep up with friends, upload an unlimited number of photos, post links and videos, and learn more about the people they meet.” View full resource at facebook.com
Most Recently Shared on May 10, 2012 at 5:28 pm By:
Most Recently Shared on September 6, 2011 at 9:57 pm By:
ehealthme.com — “Real world drug outcomes: Claritin side effects from FDA and user community. See what the side effects are and what may happen after long term use of Claritin” View full resource at ehealthme.com
Most Recently Shared on December 2, 2011 at 11:18 pm By:
health.yahoo.net — “MONDAY, Jan. 10 (HealthDay News) -- People over age 65 are at increased risk for serious side effects while undergoing latent tuberculosis therapy, a new study finds.” View full resource at health.yahoo.net
Most Recently Shared on January 11, 2011 at 5:51 am By:
Most Recently Shared on April 11, 2012 at 3:58 pm By:
Most Recently Shared on June 12, 2010 at 5:00 pm By:
Most Recently Shared on April 15, 2010 at 10:23 pm By:
thirdage.com — “Braces maker Invisalign has been warned it could face fines for not telling patients about potential serious side effects when using the product. Align Technology, makers of Invisalign, say they received a letter Tuesday from the Food and Drug” View full resource at thirdage.com
Most Recently Shared on December 3, 2010 at 1:14 pm By:
Most Recently Shared on June 6, 2009 at 6:02 pm By:
webmd.com — “An overview of probiotics " their benefits and how they work, supplements and foods with probiotics, the best probiotics for different conditions, and possible side effects.” View full resource at webmd.com
Most Recently Shared on June 14, 2010 at 11:04 pm By:
Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug, Hematide/peginesatide, Following Meeting with FDA
drugs.com — “Hematide (peginesatide) is a new drug in development for the treatment of anemia in chronic renal failure. Hematide information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on December 1, 2010 at 11:06 pm By:
sciencedaily.com — “A study by a team of University of Kentucky researchers has shed new light on the potential habit-forming properties of the popular pain medication tramadol.” View full resource at sciencedaily.com
Most Recently Shared on September 27, 2012 at 2:23 pm By:
informationweek.com — “By applying analytics to medical journal articles, Rand researchers were able to uncover dangerous side effects before regulators' existing systems could.” View full resource at informationweek.com
Most Recently Shared on May 19, 2011 at 2:01 pm By:
prescriptiondrug-info.com — “Dr advised me to take Zerodol TH 4 for my waste pain What is the side effect the medicine ... Learn about and discuss Zerodol Th4 at The People's Medicine Community. (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on March 28, 2012 at 4:05 pm By:
Most Recently Shared on May 1, 2012 at 2:05 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
Aviisha Sleep & Wellness Medical Institute educates patients and doctors about sleep disorders, weight loss, exercise, and more. Check our site for more info.
Dr. Kent Bottles has held a number of leadership positions in academia, biotechnology, and community health systems.
At the University of California, San Francisco, the University of Iowa, Allegheny University of Health Sciences, and Michigan State University College of Human Medicine, he has served as tenured professor, chair, medical director of managed care, corporate operations officer for ambulatory services, assistant dean, residency director, designated institutional officer, and elected medical school executive committee member.
He has led strategic planning exercises for the Department of Pathology at the University of Iowa, the clinical enterprise at the University of Iowa Hospitals and Clinics, the Grand Rapids Medical Education and Research Consortium, and the quality programs at the Iowa Health System.
Dr. Bottles has facilitated medical staff and hospital system board retreats centered on physician integration and engagement in evidence-based medicine and quality initiatives, and he has lectured extensively for the Governance Institute on a variety of planning topics.
In biotechnology, Dr. Bottles has served as president of the Genomics Repository, chief knowledge officer, and managing director. During his tenure at Genomics Collaborative in Cambridge, Massachusetts he raised $36 million in venture capital.
Dr. Bottles served as president of the Institute for Clinical Systems Improvement (ICSI) and as chief medical officer of the Iowa Health System, a $2 billion integrated community health system in the Midwest. At the Iowa Health System, Dr. Bottles developed and implemented a Physician Leadership Academy for over 200 physician leaders. He also was heavily involved in health information technology (HIT) implementation issues.
At ICSI he developed a physician leadership academy and also frequently lectured on leadership for St. Thomas University. Dr. Bottles currently serves on a National Quality Forum committee on quality.
Dr. Bottles has been active in lecturing and writing about leadership topics. He has contributed articles to the Physician Executive Journal of the American College of the Physician Executives,Trustee Magazine, and the op-ed page of The New York Times.
Dr. Bottles was awarded the Rodney T. West Literature Award for the most important medical management article published in 2001, and the Kaiser Teaching Award at the University of California, San Francisco. He received his B.A. from the University of California, Berkeley, and his M.D. from the Case Western Reserve University School of Medicine.]
eHealthMe provides health professionals and patients personalized tools to study millions of drug reports from FDA and community in real time.